S.369 - Preserve Access to Affordable Generics Act

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. view all titles (3)

All Bill Titles

  • Official: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. as introduced.
  • Short: Preserve Access to Affordable Generics Act as introduced.
  • Short: Preserve Access to Affordable Generics Act as reported to senate.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Interests that support this bill:

Top recipients for ALL supporting interest groups

Name Amount Received Vote On Passage
Sen. Barbara A. Mikulski [D, MD] $5,000
Sen. Michael F. Bennet [D, CO] $3,000
Sen. Christopher Murphy [D, CT] $3,000
Sen. Richard Blumenthal [D, CT] $2,500
Sen. Benjamin L. Cardin [D, MD] $2,500
Sen. Harry Reid [D, NV] $2,000
Sen. Martin Heinrich [D, NM] $2,000
Sen. Ron Wyden [D, OR] $2,000
Sen. Max Baucus [D, MT] $2,000
Sen. Robert P. Casey, Jr. [D, PA] $1,500
 
Rep. Nancy Pelosi [D, CA-12] $7,500
Rep. Charles B. Rangel [D, NY-13] $5,500
Rep. Mike Thompson [D, CA-5] $5,250
Rep. John Lewis [D, GA-5] $4,250
Rep. Bill Foster [D, IL-11] $4,000
Rep. Rosa L. DeLauro [D, CT-3] $3,500
Rep. Peter A. DeFazio [D, OR-4] $3,500
Rep. Gerald E. Connolly [D, VA-11] $3,000
Rep. Daniel B. Maffei [D, NY-24] $3,000
Rep. Alan Grayson [D, FL-9] $3,000

Specific Organizations Supporting S.369

  • Prescription Access Litigation
  • American Antitrust Institute
  • Alliance for Retired Americans
  • Consumer Union
  • Federal Trade Commission
  • American Association of Retired Persons
  • Apotex Inc.
  • Nephron Pharmaceuticals Corporation

Interests that oppose this bill:

Top recipients for ALL opposing interest groups

Name Amount Received
Sen. Richard Burr [R, NC] $114,100
Sen. Harry Reid [D, NV] $78,200
Sen. Charles E. Schumer [D, NY] $64,000
Sen. Kirsten Gillibrand [D, NY] $63,500
Sen. Orrin G. Hatch [R, UT] $59,100
Sen. Robert Menendez [D, NJ] $58,400
Sen. Barbara A. Mikulski [D, MD] $57,724
Sen. Tom Coburn [R, OK] $51,500
Sen. Patty Murray [D, WA] $50,550
Sen. Roy Blunt [R, MO] $49,600
 
Rep. Anna G. Eshoo [D, CA-18] $81,550
Rep. Dave Camp [R, MI-4] $66,250
Rep. Steny H. Hoyer [D, MD-5] $59,500
Rep. John A. Boehner [R, OH-8] $56,500
Rep. James E. Clyburn [D, SC-6] $56,250
Rep. Michael E. Capuano [D, MA-7] $52,850
Rep. Leonard Lance [R, NJ-7] $52,600
Rep. Mike Rogers [R, MI-8] $50,750
Rep. Eric Cantor [R, VA-7] $50,000
Rep. Allyson Y. Schwartz [D, PA-13] $48,822

Specific Organizations Opposing S.369

  • Pharmaceutical Research and Manufacturers of America
  • Teva Pharmaceuticals Industries Ltd.
  • Endo Pharmaceuticals Inc.
  • Mylan Laboratories

Vote on This Bill

94% Users Support Bill

47 in favor / 3 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC
Save to Notebook Make A Bill Widget

Top-Rated Comments

OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.